Chester County News and Community Website
WILMINGTON, DE — The U.S. Food and Drug Administration has accepted and granted Priority Review to a supplemental application for ENHERTU, a breast cancer treatment developed by AstraZeneca and Daiichi …
FDA Grants Priority Review to ENHERTU for Early Breast Cancer Use Read More
WILMINGTON, DE — Onfolio Holdings Inc. (Nasdaq: ONFO, ONFOW) (OTC: ONFOP) said its board of directors has declared a quarterly dividend of $0.75 per share on the company’s Series A …
Onfolio Holdings Declares $0.75 Quarterly Dividend on Preferred Shares Read More
WILMINGTON, DE — Zymtrace said it has raised $12.2 million to date, including a newly closed $8.5 million seed round, to expand its platform designed to identify performance bottlenecks in …
Zymtrace Raises $8.5 Million Seed Round to Expand AI Infrastructure Platform Read More
WILMINGTON, DE — G-Stacker, an SEO automation platform developed by Ferdinand Mehlinger, has been approved for listing on the Google Workspace Marketplace, making the application available to users of Google’s …
G-Stacker Approved for Listing on Google Workspace Marketplace Read More
WILMINGTON, DE — At least 150 local governments across 17 states have enacted moratoriums, bans, or other restrictions on battery energy storage systems, according to a nationwide database compiled by …
Carina Energy Database Tracks U.S. Battery Storage Moratoriums Read More
WILMINGTON, DE — Global Indemnity Group LLC (Nasdaq: GBLI) reported financial results for the year ended December 31, 2025, citing improved underwriting performance during the year despite losses related to …
Global Indemnity Group Reports 2025 Financial Results Read More
WILMINGTON, DE — Prelude Therapeutics Inc. (Nasdaq: PRLD) reported its financial results for the year ended December 31, 2025, and provided updates on its oncology drug development pipeline, including regulatory …
Prelude Therapeutics Reports 2025 Results and Advances Oncology Pipeline Read More
WILMINGTON, DE — The European Commission has approved Zynyz (retifanlimab), developed by Incyte (Nasdaq: INCY), in combination with carboplatin and paclitaxel for the first-line treatment of adults with metastatic or …
Incyte Drug Zynyz Approved in Europe for Anal Canal Cancer Treatment Read More
WILMINGTON, DE — Qnity Electronics Inc. (NYSE: Q) announced it has acquired a semiconductor research and manufacturing facility in Taiwan for $61.5 million to expand production capacity and meet growing …
Qnity Electronics Acquires Taiwan Facility to Expand Semiconductor Capacity Read More
WILMINGTON, DE — Phreesia announced that Tara Sheehy, senior director of client experience for Phreesia Network Solutions, has been named to the MM+M Women to Watch class of 2026.
Phreesia Executive Tara Sheehy Named to MM+M Women to Watch List Read More